UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000012136 |
|---|---|
| Receipt number | R000014190 |
| Scientific Title | Pathological analysis of activated glomerular parietal epithelial cells in children |
| Date of disclosure of the study information | 2013/10/28 |
| Last modified on | 2022/05/05 09:06:34 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Pathological analysis of activated glomerular parietal epithelial cells in children
Acronym
Pathological analysis of activated glomerular parietal epithelial cells in children
Scientific Title
Pathological analysis of activated glomerular parietal epithelial cells in children
Scientific Title:Acronym
Pathological analysis of activated glomerular parietal epithelial cells in children
Region
| Japan |
Condition
Condition
Pediatric renal disease
Classification by specialty
| Nephrology | Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the role of CD44 positive glomerular parietal epithelial cells in children with renal disease
Basic objectives2
Others
Basic objectives -Others
To clarify the physiology of glomerulosclerosis
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
renal impairment, proteinuria, hypertension
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| 20 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Age to 20 years
2) Renal biopsy has been performed for diagnosis pediatric renal disease
3) Written informed consent from patient's parents or legal guardians.
Key exclusion criteria
1) All specimen was necessary for diagnosis renal disease.
2) Judged inappropriate for this study by the physicians.
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Takayuki |
| Middle name | |
| Last name | Okamoto |
Organization
Hokkaido University Graduate School of Medicine
Division name
Department of Pediatrics
Zip code
060-8638
Address
North 15, West 7, Kita-Ku, Sapporo
TEL
+81-11-706-5954
okamon@med.hokudai.ac.jp
Public contact
Name of contact person
| 1st name | Takayuki |
| Middle name | |
| Last name | Okamoto |
Organization
Hokkaido University Graduate School of Medicine
Division name
Department of Pediatrics
Zip code
060-8638
Address
North 15, West 7, Kita-Ku, Sapporo
TEL
+81-11-706-5954
Homepage URL
okamon@med.hokudai.ac.jp
Sponsor or person
Institute
Hokkaido University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Hokkaido University Hospital Clinical Research and Medical Innovation Center
Address
North 14, West 5, Kita-Ku, Sapporo
Tel
011-706-7061
crjimu@huhp.hokudai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 10 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2013 | Year | 10 | Month | 01 | Day |
Date of IRB
| 2013 | Year | 10 | Month | 23 | Day |
Anticipated trial start date
| 2013 | Year | 10 | Month | 30 | Day |
Last follow-up date
| 2022 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To clarify the association between the expression of activated parietal epithelial cells and clinical manifestations in children with renal disease.
Management information
Registered date
| 2013 | Year | 10 | Month | 28 | Day |
Last modified on
| 2022 | Year | 05 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014190
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
